PLK1 and cancer: Different studies have shown that inhibiting PLK1 using RNAi or small molecule inhibitors interferes with cancer cell proliferation [19,20,21,22] and this has fostered the development of PLK1 inhibitors (PLK1is) as new anti-cancer drugs [23].